Pulmonary thrombotic microangiopathic hemolytic anemia treated successfully with anticoagulant monotherapy

Internal Medicine

Volumn 49, Issue 12, 2010, Pages 1217-1220

  Ishigaki, Kazuyoshi ^a   Takizawa, Yasunobu ^a   Maruyama, Junko ^a   Setoguchi, Keigo ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Anticoagulant therapy; Antiphospholipid syndrome; Plasma exchange; Pulmonary hypertension; Thrombotic microangiopathic hemolytic anemia

Indexed keywords

BILIRUBIN; HAPTOGLOBIN; MEPREDNISONE; PREDNISOLONE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; WARFARIN;

AGED; ANEMIA; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; BRAIN INFARCTION; CASE REPORT; CHOLANGITIS; CHOLECYSTECTOMY; CLINICAL FEATURE; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DYSARTHRIA; ECHOCARDIOGRAPHY; ERYTHROCYTE DISORDER; EYE JAUNDICE; FATIGUE; FEMALE; HEMIPARESIS; HEMOLYTIC ANEMIA; HUMAN; LABORATORY TEST; NORMOCYTIC ANEMIA; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RETICULOCYTOSIS; SYSTOLIC HEART MURMUR; THROMBOCYTOPENIA; THROMBOTIC MICROANGIOPATHIC HEMOLYTIC ANEMIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; WEIGHT REDUCTION;

AGED; ANEMIA, HEMOLYTIC; ANTICOAGULANTS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; PURPURA, THROMBOTIC THROMBOCYTOPENIC; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME;

EID: 77954011357     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3315     Document Type: Article

References (8)

1. Symmers WS. Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy). Br Med J 2: 897-903, 1952.
2. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 346: 752-763, 2002.
3. George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 96: 1223-1229,2000.
4. Espinosa G, Bucciarelli S, Cervera R, et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 63: 730-736, 2004.
5. Furlan M, Robles R, Galbusera M, et al. von Willebrand factorcleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339: 1578-1584, 1998.
6. Asherson RA, Pierangeli S, Cervera R. Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromes. J Rheumatol 34: 1793-1795, 2007.
7. Pierangeli SS, Girardi G, Vega-Ostertag M, Liu X, Espinola RG, Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 52: 2120-2124, 2005.
8. Oku K, Atsumi T, Bohgaki M, et al. Complement activation in patients with primary antiphospholipid syndrome. Ann Rheum Dis 68: 1030-1035, 2009.